Literature DB >> 23224434

The tumor suppressor protein menin inhibits NF-κB-mediated transactivation through recruitment of Sirt1 in hepatocellular carcinoma.

Ding Gang1, Hua Hongwei, Liu Hedai, Zhang Ming, Huang Qian, Liao Zhijun.   

Abstract

Oncogenic activation of the NF-κB signaling pathway is common in hepatocellular carcinoma (HCC). However, the molecular mechanisms remain largely unexplored. Previous studies have demonstrated that menin, a tumor suppressor protein, could interact with NF-κB protein and repress p65-mediated transcriptional activation. In the present study, we found that expression of menin was frequently down-regulated in HCC tissues and cells. Furthermore, menin could repress p65 acetylation through recruitment of Sirt1, an enzyme that deacetylases p65 in lysine 310 (K310). Indeed, Sirt1 inhibitor or its specific small interfering RNA abolished the inhibitory roles of menin. Together, these observations suggest that the interaction between menin and Sirt1 is required for the tumor suppressor function of menin in HCC.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23224434     DOI: 10.1007/s11033-012-2326-0

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  27 in total

Review 1.  The role of menin in parathyroid tumorigenesis.

Authors:  Colin Davenport; Amar Agha
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 2.  NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses.

Authors:  S Ghosh; M J May; E B Kopp
Journal:  Annu Rev Immunol       Date:  1998       Impact factor: 28.527

Review 3.  Sirtuins as regulators of metabolism and healthspan.

Authors:  Riekelt H Houtkooper; Eija Pirinen; Johan Auwerx
Journal:  Nat Rev Mol Cell Biol       Date:  2012-03-07       Impact factor: 94.444

4.  Acetylation of RelA at discrete sites regulates distinct nuclear functions of NF-kappaB.

Authors:  Lin-feng Chen; Yajun Mu; Warner C Greene
Journal:  EMBO J       Date:  2002-12-02       Impact factor: 11.598

Review 5.  Cytokine overexpression and constitutive NFkappaB in cancer.

Authors:  Tao Lu; George R Stark
Journal:  Cell Cycle       Date:  2004-09-04       Impact factor: 4.534

6.  STAT3 inhibition of gluconeogenesis is downregulated by SirT1.

Authors:  Yongzhan Nie; Derek M Erion; Zhenglong Yuan; Marcelo Dietrich; Gerald I Shulman; Tamas L Horvath; Qian Gao
Journal:  Nat Cell Biol       Date:  2009-03-22       Impact factor: 28.824

7.  Function of the SIRT1 protein deacetylase in cancer.

Authors:  Walter Stünkel; Bee Keow Peh; Yong Cheng Tan; Vasantha M Nayagam; Xukun Wang; Manuel Salto-Tellez; BinHui Ni; Michael Entzeroth; Jeanette Wood
Journal:  Biotechnol J       Date:  2007-11       Impact factor: 4.677

8.  Developmental defects and p53 hyperacetylation in Sir2 homolog (SIRT1)-deficient mice.

Authors:  Hwei-Ling Cheng; Raul Mostoslavsky; Shin'ichi Saito; John P Manis; Yansong Gu; Parin Patel; Roderick Bronson; Ettore Appella; Frederick W Alt; Katrin F Chua
Journal:  Proc Natl Acad Sci U S A       Date:  2003-09-05       Impact factor: 11.205

9.  SIRT1 is significantly elevated in mouse and human prostate cancer.

Authors:  Derek M Huffman; William E Grizzle; Marcas M Bamman; Jeong-su Kim; Isam A Eltoum; Ada Elgavish; Tim R Nagy
Journal:  Cancer Res       Date:  2007-07-15       Impact factor: 12.701

Review 10.  Multiple endocrine neoplasia type 1 (MEN1): analysis of 1336 mutations reported in the first decade following identification of the gene.

Authors:  Manuel C Lemos; Rajesh V Thakker
Journal:  Hum Mutat       Date:  2008-01       Impact factor: 4.878

View more
  15 in total

1.  miR-24 Inhibition Increases Menin Expression and Decreases Cholangiocarcinoma Proliferation.

Authors:  Laurent Ehrlich; Chad Hall; Julie Venter; David Dostal; Francesca Bernuzzi; Pietro Invernizzi; Fanyin Meng; Jerome P Trzeciakowski; Tianhao Zhou; Holly Standeford; Gianfranco Alpini; Terry C Lairmore; Shannon Glaser
Journal:  Am J Pathol       Date:  2017-01-11       Impact factor: 4.307

Review 2.  A Review of the Scaffold Protein Menin and its Role in Hepatobiliary Pathology.

Authors:  Laurent Ehrlich; Chad Hall; Fanyin Meng; Terry Lairmore; Gianfranco Alpini; Shannon Glaser
Journal:  Gene Expr       Date:  2017-04-28

Review 3.  Emerging role of silent information regulator 1 (SIRT1) in hepatocellular carcinoma: a potential therapeutic target.

Authors:  Yuting Wu; Xiaoming Meng; Cheng Huang; Jun Li
Journal:  Tumour Biol       Date:  2015-05-01

Review 4.  Epigenetic regulation by the menin pathway.

Authors:  Zijie Feng; Jian Ma; Xianxin Hua
Journal:  Endocr Relat Cancer       Date:  2017-08-15       Impact factor: 5.678

Review 5.  Menin: a scaffold protein that controls gene expression and cell signaling.

Authors:  Smita Matkar; Austin Thiel; Xianxin Hua
Journal:  Trends Biochem Sci       Date:  2013-07-10       Impact factor: 13.807

6.  Chitosan nanoparticle-mediated effect of antimiRNA-324-5p on decreasing the ovarian cancer cell proliferation by regulation of GLI1 expression.

Authors:  Ysrafil Ysrafil; Indwiani Astuti
Journal:  Bioimpacts       Date:  2021-11-29

7.  MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN.

Authors:  Yao-Qi Yang; Jin Qi; Jian-Qiang Xu; Ping Hao
Journal:  Tumour Biol       Date:  2014-07-18

8.  Downregulation of tumor suppressor menin by miR-421 promotes proliferation and migration of neuroblastoma.

Authors:  Yu Li; Wei Li; Jian-Guo Zhang; Hai-Yang Li; Yong-Ming Li
Journal:  Tumour Biol       Date:  2014-07-11

Review 9.  The future: genetics advances in MEN1 therapeutic approaches and management strategies.

Authors:  Sunita K Agarwal
Journal:  Endocr Relat Cancer       Date:  2017-10       Impact factor: 5.678

10.  A reproducible approach to high-throughput biological data acquisition and integration.

Authors:  Daniela Börnigen; Yo Sup Moon; Xochitl C Morgan; Wendy S Garrett; Gholamali Rahnavard; Levi Waldron; Lauren McIver; Afrah Shafquat; Eric A Franzosa; Larissa Miropolsky; Christopher Sweeney; Curtis Huttenhower
Journal:  PeerJ       Date:  2015-03-31       Impact factor: 2.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.